Valuation
MEDMedifast Inc
StockNYSEUnited StatesConsumer staplesEU retail investors: available
−2.5% today · +10.5% over a year
No score: too little data.
Quality, Stability: among the weakest. No dividend.
Medifast Inc (MED) valuation against sector peers: P/B 0.8, free-cash-flow yield −2.7%, P/S 0.5.
Ratios vs sector
Medians of Consumer staples companies in the same region (stocks and REITs).
| Metric | MED | Sector median | vs median |
|---|---|---|---|
| P/E | — | 23.7 · n=71 | — |
| P/B | 0.8 | 2.3 · n=83 | 64% below |
| P/S | 0.5 | 0.8 · n=89 | 41% below |
| EV/EBIT | — | 20.6 · n=67 | — |
| Free-cash-flow yield | −2.7% | 5.3% · n=87 | 150% below |
| Dividend yield | 0.00% | 1.72% · n=97 | 100% below |
| Return on equity | −20.7% | 10.8% · n=88 | 291% below |
| Return on invested capital | −29.3% | 8.6% · n=88 | 439% below |
| Gross margin | 69.2% | 32.5% · n=95 | 113% above |
| Net debt / EBITDA | — | 1.74 · n=77 | — |
Sector peers
The largest companies of the same sector and region.
| WMTWalmart | 45.1 | 10.1 | 31.9 | 1.4% | 0.8% | 6/10 |
|---|---|---|---|---|---|---|
| COSTCostco Wholesale | 51.2 | 13.2 | 39.1 | 2.0% | 0.5% | 8/10 |
| KOCoca-Cola | 28.5 | 11.2 | 29.2 | 3.4% | 2.2% | 9/10 |
| PGProcter & Gamble | 24.8 | 7.2 | 21.0 | 3.9% | 3.2% | 8/10 |
| PMPhilip Morris | 28.3 | — | 20.7 | 4.5% | 3.1% | 10/10 |
| PEPPepsiCo | 23.8 | 9.6 | 20.8 | 3.9% | 4.0% | 6/10 |
| MOAltria Group | 15.7 | — | 13.4 | 7.1% | 5.6% | 10/10 |
| MNSTMonster Beverage | 40.9 | 9.0 | 31.1 | 2.2% | 0.0% | 6/10 |
| MDLZMondelez | 20.7 | 3.2 | 19.1 | 4.3% | 3.0% | 6/10 |
| CLColgate-Palmolive | 38.0 | 270.7 | 26.6 | 4.9% | 2.7% | 8/10 |
Fiscal-year history
From annual SEC filings; each bar is a fiscal year, labelled by the year it ended.
Filings: U.S. SEC EDGAR · ratios computed by AI-Stock Invest from public filings and end-of-day prices · latest period 30 Sep 2026 · filed 26 Oct 2026
Withdraw from contract here · EU consumers: 14 days to withdraw from a purchase.